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INTRODUCTION:  Gastrointestinal  stromal  tumors  (GISTs)  are  the  leading  mesenchymal  neoplasia  in  the
gastrointestinal  tract,  but GIST  arising  from  the  rectum  is  rare.  When  a secondary  neoplasia  coexists  in
the  vicinity  of a  rectal GIST,  more  aggressive  treatment  strategies  may  be needed  to  cure  the  diseases.
PRESENTATION  OF  CASE:  We  herein  describe  a 76-year-old  man  with  a large  gastrointestinal  stromal
tumor  along  with an  advanced  adenocarcinoma  in  the  rectum  that coexisted  with  prostate  carcinoma.
Preoperative  examination  revealed  an advanced  adenocarcinoma  of  the  upper  rectum  and  a large  pelvic
mass suggestive  of a GIST  or a neuroendocrine  tumor  arising  from  the  anterior  wall  of the  lower  rectum.  To
eradicate  the  tumor,  total pelvic  exenteration  with  ureterocutaneous  ﬁstula  was  carried out  after  obtain-
ing written  informed  consent.  Immuhistochemical  studies  revealed  the  concurrence  of  an  advanced
rectal  cancer  (T3,  N1, M0)  and  a malignant  GIST  (c-kit-positive,  CD34-positive,  vimentin-positive,  and
CAM5.2-negative),  and  an incidental  prostatic  acinar  adenocarcinoma.  The  patient  was  given adjuvant
chemotherapy  with  imatinib  and  remains  disease-free  as  of  12 months  after  surgery.
DISCUSSION:  A PubMed  search  for the  case  of  coexistence  of GIST  with  two  other  malignancies  revealed
only  four  cases,  making  this  very  rare condition.
CONCLUSION:  Radical  surgery  with  perioperative  adjuvant  chemotherapy  using  tyrosine  kinase  inhibitors
is the  choice  for  treatment  of  large  GISTs  with  a  malignant  potential.  Our  report  suggests  that  aggressive
surgical  approach  would  be feasible,  when  a  secondary  tumor  is  present  near  the  GIST.
©  2014  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
The most common location of gastrointestinal stromal tumor
GIST) is the stomach (60–70%) followed by the small intestine
20–25%), as compared to only approximately 5% in the rectum.1,2
The coexistence of GIST with other epithelial cancers of differ-
nt histological types has been reported, where the second tumor
an develop synchronously or metachronously.3 Of interest are
hose cases in which one or more tumors were located within the
ame organ. When a secondary neoplasia coexists in the vicinity
f a GIST, more aggressive treatment strategies would be needed
o cure the diseases. We  report a patient who underwent a total
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210-2612/© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical A
http://creativecommons.org/licenses/by-nc-nd/3.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
pelvic exenteration for a rectal GIST concurrent with an advanced
rectal cancer and an incidental prostate cancer.
2. Case report
A 76-year-old man  suffered from constipation for 6 months. At
the age of 26 years, he had undergone an appendectomy. The family
history of the patient was  unremarkable. He visited a local hospital
where digital examination revealed a tumor with a hard, elastic
and smooth surface in the anterior wall of the rectum at about
4 cm above the dentate line. Magnetic resonance imaging (MRI)
showed a mass with a smooth margin, 7 cm × 5 cm in size mainly
occupying the anterior wall of the lower rectum (Fig. 1). These
ﬁndings suggested a GIST or rectal carcinoid originating from the
rectal wall. The biopsy was avoided for the risk of intra-abdominal
seeding or tumor rupture. Then he was  referred to our hospital
for further examination and treatment. Laboratory examination
was unremarkable. Colonoscopy revealed an irregular tumor in
the rectosigmoid colon approximately 15 cm from the anal verge,
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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Rig. 1. Magnetic resonance imaging. (A) Transverse T1-weighted image showing a ho
mage  showing a heterogeneous mass with high signal intensity (arrow). (C) Sagittal
arrow).
side from the pelvic tumor, and biopsy of the tumor demon-
trated moderately differentiated adenocarcinoma. However, no
isible mucosal abnormality relevant to the pelvic tumor was
ound. Contrast-enhanced computed tomography (CT) showed an
rregular circumferential mural thickening involving the rectosig-
oid colon with no enlarged lymph nodes and a solitary irregular
nd low-density mass in the lower rectum extending from the ante-
ior rectal wall into the prostate. No distant metastasis including
he liver was found.
Based on these ﬁndings, the patient was judged to have ade-
ocarcinoma of the upper rectum concurrent with a malignant
ubmucosal tumor of the lower rectum. To minimize the risk of
umor spread during the dissection between a large fragile GIST
nd the prostate in the lower pelvic cavity and to accomplish com-
lete en bloc resection of the two concomitant malignant tumors,
otal pelvic exenteration (TPE) with ureterocutaneous ﬁstula was
elected (Fig. 2). At operation, a 3 cm well-circumscribed nodule
as identiﬁed in the mesentery of the sigmoid colon, and there-
ore ﬁne needle aspiration biopsy of the pelvic tumor and incisional
iopsy of the mesenteric was performed. However both specimens
ailed to identify malignancy.
Postoperatively, histopathological examination of the surgical
pecimen revealed a moderately differentiated rectal adenocarci-
oma (T3, N1, M0), rectal GIST with the same pathology as the
esenteric nodule with malignant biological behavior, and an inci-
ional prostatic acinar adenocarcinoma with a combined Gleason
core of 6 (3 + 3) that was conﬁned to the left prostate lobes.
Further examination of rectal GIST revealed stromal cell neo-
lasm with necrotic and hemorrhagic areas and large tumor size
>5 cm), a high index of mitotic count: above 5 mitoses per
igh-power ﬁelds (HPF). Immunohistochemical analysis revealed
ositive staining for CD117 (c-kit), CD-34 and Vimentin, and neg-
tive CAM5.2 (Fig. 3). Based on the histopathological ﬁnding, the
ig. 2. (A) Resected specimen showing concurrent rectal GIST and adenocarcinoma of rec
:  rectum.neous mass with intermediate signal intensity (arrow). (B) Transverse T2-weighted
ighted image could not show clear delineation between the tumor and the prostate
GIST was diagnosed as a high grade malignancy. Resection margins
were free of both the tumors. Although the postsurgical recovery
was uneventful, the patient wanted to receive postoperative reha-
bilitation in the hospital as long as possible and was discharged on
postoperation day 46.
Following the histopathological conﬁrmation, treatment with
imatinib was initiated on postoperative day 60. The imatinib was
introduced at a dose of 400 mg/day in order to minimize the risk
of relapse associated with the drug interruption. Postoperatively,
patient was  followed up with CT at 12 months after the operation;
no metastasis has been observed.
3. Discussion
GISTs are the most common type of non-epithelial neoplasia
diagnosed in the gastrointestinal tract (0.1–3% of all gastrointesti-
nal tumors) and expresses CD117, a c-kit proto-oncogene, which
can be detected immunohistochemically.4
Recently, cases of synchronous or metachronous development
of GISTs and concomitant another neoplasm with different inci-
dence, etiology, evolution and prognosis have been reported. Abbas
et al. reported about 10% of patients with GISTs develop other can-
cers either synchronously or metachronously.5 The major types
of GIST-associated malignancies reported in the literature include
gastrointestinal carcinomas, lymphoma/leukemia, gynecological
carcinomas, and carcinomas of the prostate, breast, pancreas, lung,
liver or kidney as well as carcinoid of the pancreas or stomach.5–7
Regarding the simultaneous development of GIST and other can-
cers, various hypotheses such as gene mutation, expression of
metallothioneins, neighboring tissues being inﬂuenced by the same
carcinogens, have been proposed.8,9 However, the limited num-
ber of such cases cannot conﬁrm the existence of a common factor
in tumorigenesis of these histopathologically completely different
tum. (B) Rectal GIST without prostatic inﬁltration. UB: urinary bladder; P: prostate;
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cig. 3. Microscopic images. (A) Rectal adenocarcinoma (H-E stain, ×20). (B) Prostat
istochemistry indicating strong staining for CD117 (D, ×20), and CD-34 (E, ×40). (
umors. Simple coincidence could be the most reasonable explana-
ion.
What is unique in our case is that coexistence of GIST of the
ectum with two  other malignancies. To our knowledge, only four
ases of coexistence of GIST with multiple other malignancies have
een reported.5,10 In all four such cases, GISTs coexisted with malig-
ancies of distant organs. The current case seems to be the ﬁrst
eport wherein a coexistence of GIST of the rectum, coexisted with
ectal adenocarcinoma and prostate carcinoma within neighboring
rgans and resected together in a single surgical specimen is being
eported. The majority of the coexistent GISTs are discovered inci-
entally during work-up or during therapeutic procedures for GI
alignancies. In the current case, coexistence of rectal adenocarci-
oma and prostate carcinoma was discovered incidentally, during
xamination and post laparotomy, respectively.
Neoadjuvant chemotherapy was not selected, because the pre-
perative diagnosis of GIST was not conﬁrmative and complete
esection of the tumors was possible with TPE. And furthermore,
o reduce the tumor size and achieve a restorative surgery with
ncreased costs, the beneﬁt and risk of neoadjuvant imatinib ther-
py for a rectal GIST were discussed.
Adjuvant therapy for GIST was started according to a growing
vidence supporting the beneﬁts of tyrosine kinase inhibitors after
urgical resection of GISTs with a high malignant potential.
. Conclusion
A second malignant tumor is not so rare in patients who  undergo
r had undergone surgery for GISTs, because aging is the important
isk factor for GISTs and cancers. The treatment strategy for GISTs
ould be altered by the biological features of a concurrent tumor.
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